EW vs. SYK

In the year-to-date period, EW achieves a -0.47% return, which is significantly lower than SYK's 6.04% return. Over the past 10 years, EW has underperformed SYK with an annualized return of 13.01%, while SYK has yielded a comparatively higher 16.52% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EW Sharpe Ratio is -0.38, which is lower than the SYK Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of EW and SYK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

EW has not paid dividends to shareholders, while SYK's dividend yield for the trailing twelve months is around 0.86%.

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum SYK drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for EW and SYK. For additional features, visit the drawdowns tool.

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Stryker Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.